Role of serine-threonine phosphoprotein phosphatases in smooth muscle contractility

American Journal of Physiology - Cell Physiology

Volumn 304, Issue 6, 2013, Pages

  Butler, Trent ^a,b   Paul, Jonathan ^a,b   Europe Finner, Nick ^c   Smith, Roger ^a,b   Chan, Eng Cheng ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Contraction; Dephosphorylation; Ion channel; Myometrium; Myosin; Myosin light chain 20; Myosin phosphatase regulatory targeting subunit 1; Phosphorylation; Pregnancy; Protein phosphatase 1; Protein phosphatase 2A; Protein phosphatase 2B

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PHOSPHOPROTEIN PHOSPHATASE; SERINE; THREONINE; ION CHANNEL; MYOSIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN PHOSPHATASE; PPP1R12A PROTEIN, HUMAN;

ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HYPERPLASIA; MUSCLE HYPERTROPHY; MYOMETRIUM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE CONTRACTION; UTERUS CONTRACTILITY; ANIMAL; ENZYMOLOGY; FEMALE; METABOLISM; MOUSE; MUSCLE CONTRACTION; PHOSPHORYLATION; PHYSIOLOGY; RAT; SMOOTH MUSCLE;

ANIMALS; FEMALE; HUMANS; ION CHANNELS; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOMETRIUM; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; MYOSINS; PHOSPHORYLATION; PREGNANCY; RATS;

MLCS; MLOWN;

EID: 84877259945     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00161.2012     Document Type: Review

References (283)

1. Abe A, Karaki H. Synergistic effects of cyclic AMP-related vasodilators and the phosphatase inhibitor okadaic acid. Jpn J Pharmacol 63: 129-131, 1993.
2. Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 49: 921-956, 1980.
3. Aitken A, Klee CB, Cohen P. The structure of the B subunit of calcineurin. Eur J Biochem 139: 663-671, 1984.
4. Alessi D, MacDougall LK, Sola MM, Ikebe M, Cohen P. The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phospha-tase-1. Eur J Biochem 210: 1023-1035, 1992.
5. Allen BG, Walsh MP. The biochemical basis of the regulation of smooth-muscle contraction. Trends Biochem Sci 19: 362-368, 1994.
6. Alvarez SM, Miner AS, Browne BM, Ratz PH. Failure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels. Br J Pharmacol 160: 1326-1337, 2010.
7. Amberg GC, Koh SD, Perrino BA, Hatton WJ, Sanders KM. Regu-lation of A-type potassium channels in murine colonic myocytes by phosphatase activity. Am J Physiol Cell Physiol 281: C2020-C2028, 2001.
8. Amberg GC, Rossow CF, Navedo MF, Santana LF. NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem 279: 47326-47334, 2004.
9. Andreeva AV, Kutuzov MA. PPEF/PP7 protein Ser/Thr phosphatases. Cell Mol Life Sci 66: 3103-3110, 2009.
10. Arteche ME, Ausina P, Delgado J, Fernandez JJ, Norte M, Candenas ML, Martin JD. Inhibitory effects of okadaic acid on rat uterine contractile responses to different spasmogens. Fundam Clin Pharmacol 11: 47-56, 1997.
11. Ashizawa N, Kobayashi F, Tanaka Y, Nakayama K. Relaxing action of okadaic acid, a black sponge toxin, on the arterial smooth muscle. Biochem Biophys Res Commun 162: 971-976, 1989.
12. Ayres AW, Carr DW, McConnell DS, Lieberman RW, Smith GD. Expression and intracellular localization of protein phosphatases 2A and 2B, protein kinase a, A-kinase anchoring protein (AKAP79), and binding of the regulatory (RII) subunit of protein kinase A to AKAP79 in human myometrium. J Soc Gynecol Investig 10: 428-437, 2003.
13. Bardou M, Cortijo J, Loustalot C, Taylor S, Perales-Marin A, Mercier FJ, Dumas M, Deneux-Tharaux C, Frydman R, Morcillo EJ, Advenier C. Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium. Naunyn Schmiedebergs Arch Pharmacol 360: 457-463, 1999.
14. Beall A, Bagwell D, Woodrum D, Stoming TA, Kato K, Suzuki A, Rasmussen H, Brophy CM. The small heat shock-related protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-depen-dent relaxation. J Biol Chem 274: 11344-11351, 1999.
15. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J, Lutsch G. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem 269: 20780-20784, 1994.
16. Berrou E, Bryckaert M. Recruitment of protein phosphatase 2A to dorsal ruffles by platelet-derived growth factor in smooth muscle cells: dephosphorylation of Hsp27. Exp Cell Res 315: 836-848, 2009.
17. Bhetwal BP, An CL, Fisher SA, Perrino BA. Regulation of basal LC20 phosphorylation by MYPT1 and CPI-17 in murine gastric antrum, gastric fundus, and proximal colon smooth muscles. Neurogastroenterol Motil 23: e425-e436, 2011.
18. Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256: 283-290, 1988.
19. Bitar KN, Ibitayo A, Patil SB. HSP27 modulates agonist-induced association of translocated RhoA and PKC? in muscle cells of the colon. J Appl Physiol 92: 41-49, 2002.
20. Bitar KN, Kaminski MS, Hailat N, Cease KB, Strahler JR. Hsp27 is a mediator of sustained smooth muscle contraction in response to bombesin. Biochem Biophys Res Commun 181: 1192-1200, 1991.
21. Bodoor K, Lontay B, Safi R, Weitzel DH, Loiselle D, Wei Z, Lengyel S, McDonnell DP, Haystead TA. Smoothelin-like 1 protein is a bifunc-tional regulator of the progesterone receptor during pregnancy. J Biol Chem 286: 31839-31851, 2011.
22. Boghaert ER, Sells SF, Walid AJ, Malone P, Williams NM, Weinstein MH, Strange R, Rangnekar VM. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues. Cell Growth Differ 8: 881-890, 1997.
23. Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation 107: 3081-3087, 2003.
24. Borman MA, MacDonald JA, Haystead TA. Modulation of smooth muscle contractility by CHASM, a novel member of the smoothelin family of proteins. FEBS Lett 573: 207-213, 2004.
25. 2+ sensitization via myosin phosphatase inhibition. J Biol Chem 277: 23441-23446, 2002.
26. Buxton IL, Kaiser RA, Malmquist NA, Tichenor S. NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP. Br J Pharmacol 134: 206-214, 2001.
27. Buxton IL, Milton D, Barnett SD, Tichenor SD. Agonist-specific compartmentation of cGMP action in myometrium. J Pharmacol Exp Ther 335: 256-263, 2010.
28. Candenas ML, Arteche E, Norte M, Advenier C, Martin JD. Influ-ence of calcium on the effects of okadaic acid and its interaction with caffeine and theophylline in rat myometrium. Naunyn Schmiedebergs Arch Pharmacol 350: 315-321, 1994.
29. Candenas ML, Norte M, Gonzalez R, Arteche E, Fernandez JJ, Borges R, Boada J, Advenier C, Martin JD. Inhibitory and contractile effects of okadaic acid on rat uterine muscle. Eur J Pharmacol 219: 473-476, 1992.
30. Cao W, Mattagajasingh SN, Xu H, Kim K, Fierlbeck W, Deng J, Lowenstein CJ, Ballermann BJ. TIMAP, a novel CAAX box protein regulated by TGF-β1 and expressed in endothelial cells. Am J Physiol Cell Physiol 283: C327-C337, 2002.
31. Ceulemans H, Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 84: 1-39, 2004.
32. 2+regulation. Proc Natl Acad Sci USA 74: 129-133, 1977.
33. 2+/calmod-ulin-dependent protein phosphatase (calcineurin Bα2). Biochim Biophys Acta 1217: 174-180, 1994.
34. Chen FC, Ogut O, Rhee AY, Hoit BD, Brozovich FV. Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. J Mol Cell Cardiol 41: 488-495, 2006.
35. Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257: 1261-1264, 1992.
36. Chen YH, Chen MX, Alessi DR, Campbell DG, Shanahan C, Cohen P, Cohen PT. Molecular cloning of cDNA encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M. FEBS Lett 356: 51-55, 1994.
37. 2+-desensitization through activation of myosin phosphatase in phasic and tonic smooth muscle. J Muscle Res Cell Motil 25: 657-665, 2004.
38. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 58: 453-508, 1989.
39. Cohen PT. Protein phosphatase 1-targeted in many directions. J Cell Sci 115: 241-256, 2002.
40. Cohen PT. Two isoforms of protein phosphatase 1 may be produced from the same gene. FEBS Lett 232: 17-23, 1988.
41. Cohen PT, Philp A, Vazquez-Martin C. Protein phosphatase 4-from obscurity to vital functions. FEBS Lett 579: 3278-3286, 2005.
42. Cornwell TL, Li J, Sellak H, Miller RT, Word RA. Reorganization of myofilament proteins and decreased cGMP-dependent protein kinase in the human uterus during pregnancy. J Clin Endocrinol Metab 86: 3981-3988, 2001.
43. da Cruz e Silva OB, Alemany S, Campbell DG, Cohen PT. Isolation and sequence analysis of a cDNA clone encoding the entire catalytic subunit of a type-2A protein phosphatase. FEBS Lett 221: 415-422, 1987.
44. da Cruz e Silva OB, Cohen PT. A second catalytic subunit of type-2A protein phosphatase from rabbit skeletal muscle. FEBS Lett 226: 176-178, 1987.
45. Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP. Phosphor-ylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J 367: 517-524, 2002.
46. +channels contribute to 11, 12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation. Prostaglandins Other Lipid Mediat 83: 50-61, 2007.
47. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100: 121-129, 2007.
48. Dirksen WP, Vladic F, Fisher SA. A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phe-notypic switch. Am J Physiol Cell Physiol 278: C589-C600, 2000.
49. Djuric J, Arsenijevic S, Bankovic D, Protrka Z, Sorak M, Dimitrijevic A, Tanaskovic I. Dystocia as a cause of untimely cesarean section. Vojnosanit Pregl 69: 589-593, 2012.
50. Dodge KL, Carr DW, Yue C, Sanborn BM. A role for AKAP (A kinase anchoring protein) scaffolding in the loss of a cyclic adenosine 3=, 5=-monophosphate inhibitory response in late pregnant rat myome-trium. Mol Endocrinol 13: 1977-1987, 1999.
51. Doppler H, Storz P, Li J, Comb MJ, Toker A. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem 280: 15013-15019, 2005.
52. Duran C, Hartzell HC. Physiological roles and diseases of Tmem16/ anoctamin proteins: are they all chloride channels? Acta Pharmacol Sin 32: 685-692, 2011.
53. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7: 555-569, 1993.
54. Ekerhovd E, Weidegard B, Brannstrom M, Norstrom A. Nitric oxide-mediated effects on myometrial contractility at term during prela-bor and labor. Obstet Gynecol 93: 987-994, 1999.
55. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphor-ylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem 284: 35273-35277, 2009.
56. Eto M, Karginov A, Brautigan DL. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry 38: 16952-16957, 1999.
57. Eto M, Kitazawa T, Brautigan DL. Phosphoprotein inhibitor CPI-17specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc Natl Acad Sci USA 101: 8888-8893, 2004.
58. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410: 356-360, 1997.
59. Etter EF, Eto M, Wardle RL, Brautigan DL, Murphy RA. Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem 276: 34681-34685, 2001.
60. Farkas I, Dombradi V, Miskei M, Szabados L, Koncz C. Arabidopsis PPP family of serine/threonine phosphatases. Trends Plant Sci 12: 169-176, 2007.
61. Favre B, Turowski P, Hemmings BA. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 272: 13856-13863, 1997.
62. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274: 37385-37390, 1999.
63. Fetalvero KM, Zhang P, Shyu M, Young BT, Hwa J, Young RC, Martin KA. Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition. J Clin Invest 118: 3966-3979, 2008.
64. Franova S, Janicek F, Visnovsky J, Dokus K, Zubor P, Sutovska M, Nosalova G. Utero-relaxant effect of PDE4-selective inhibitor alone and in simultaneous administration with β2-mimetic on oxytocin-induced contractions in pregnant myometrium. J Obstet Gynaecol Res 35: 20-25, 2009.
65. Friel AM, Curley M, Ravikumar N, Smith TJ, Morrison JJ. Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor. J Soc Gynecol Investig 12: 20-27, 2005.
66. Fu K, Mende Y, Bhetwal BP, Baker S, Perrino BA, Wirth B, Fisher SA. Tra2β protein is required for tissue-specific splicing of a smooth muscle myosin phosphatase targeting subunit alternative exon. J Biol Chem 287: 16575-16585, 2012.
67. Fujioka M, Takahashi N, Odai H, Araki S, Ichikawa K, Feng J, Nakamura M, Kaibuchi K, Hartshorne DJ, Nakano T, Ito M. A new isoform of human myosin phosphatase targeting/regulatory subunit (MYPT2): cDNA cloning, tissue expression, and chromosomal mapping. Genomics 49: 59-68, 1998.
68. Gabella G. Structural apparatus for force transmission in smooth mus-cles. Physiol Rev 64: 455-477, 1984.
69. Gallagher PJ, Herring BP. The carboxyl terminus of the smooth muscle myosin light chain kinase is expressed as an independent protein, telokin. J Biol Chem 266: 23945-23952, 1991.
70. Gebbink MF, Kranenburg O, Poland M, van Horck FP, Houssa B, Moolenaar WH. Identification of a novel, putative Rho-specific GDP/ GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J Cell Biol 137: 1603-1613, 1997.
71. Golightly E, Jabbour HN, Norman JE. Endocrine immune interactions in human parturition. Mol Cell Endocrinol 335: 52-59, 2011.
72. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, Somlyo AV. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem 267: 14662-14668, 1992.
73. Grassie ME, Sutherland C, Ulke-Lemee A, Chappellaz M, Kiss E, Walsh MP, Macdonald JA. Cross-talk between Rho-associated kinase and cyclic nucleotide-dependent kinase signaling pathways in the regu-lation of smooth muscle myosin light chain phosphatase. J Biol Chem 287: 36356-36369, 2012.
74. 2+ channels in human vascular smooth muscle. FEBS Lett 373: 30-34, 1995.
75. 2+ channels in human vascular smooth-muscle cells. Biochem J 318: 513-517, 1996.
76. Hagerty L, Weitzel DH, Chambers J, Fortner CN, Brush MH, Loiselle D, Hosoya H, Haystead TA. ROCK1 phosphorylates and activates zipper-interacting protein kinase. J Biol Chem 282: 4884-4893, 2007.
77. Hamaguchi T, Ito M, Feng J, Seko T, Koyama M, Machida H, Takase K, Amano M, Kaibuchi K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by protein kinase N. Biochem Biophys Res Commun 274: 825-830, 2000.
78. Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J. Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics 8: 1346-1361, 2008.
79. Hemenway CS, Heitman J. Calcineurin. Structure, function, inhibition. Cell Biochem Biophys 30: 115-151, 1999.
80. Hemmings BA, Adams-Pearson C, Maurer F, Muller P, Goris J, Merlevede W, Hofsteenge J, Stone SR. α-and β-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure. Biochemistry 29: 3166-3173, 1990.
81. Herring BP, Lyons GE, Hoggatt AM, Gallagher PJ. Telokin expres-sion is restricted to smooth muscle tissues during mouse development. Am J Physiol Cell Physiol 280: C12-C21, 2001.
82. Herring BP, Smith AF. Telokin expression is mediated by a smooth muscle cell-specific promoter. Am J Physiol Cell Physiol 270: C1656-C1665, 1996.
83. Hersch E, Huang J, Grider JR, Murthy KS. Gq/G13signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETAand CPI-17 dephos-phorylation via ETB. Am J Physiol Cell Physiol 287: C1209-C1218, 2004.
84. Hinds TD Jr, Sanchez ER. Protein phosphatase 5. Int J Biochem Cell Biol 40: 2358-2362, 2008.
85. 2+ sensitization of the contractile apparatus in vascular smooth mus-cle. J Pharm Sci 104: 109-115, 2007.
86. Hodgkinson JL, Newman TM, Marston SB, Severs NJ. The structure of the contractile apparatus in ultrarapidly frozen smooth muscle: freeze-fracture, deep-etch, and freeze-substitution studies. J Struct Biol 114: 93-104, 1995.
87. Hojlund K, Bowen BP, Hwang H, Flynn CR, Madireddy L, Geetha T, Langlais P, Meyer C, Mandarino LJ, Yi Z. In vivo phosphopro-teome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS. J Proteome Res 8: 4954-4965, 2009.
88. Honkanen RE, Golden T. Regulators of serine/threonine protein phos-phatases at the dawn of a clinical era? Curr Med Chem 9: 2055-2075, 2002.
89. Huang QQ, Fisher SA, Brozovich FV. Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation. J Biol Chem 279: 597-603, 2004.
90. Hudson CA, Heesom KJ, Lopez Bernal A. Phasic contractions of isolated human myometrium are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting subunit (MYPT1). Mol Hum Reprod 18: 265-279, 2012.
91. Ikebe M. Regulation of the function of mammalian myosin and its conformational change. Biochem Biophys Res Commun 369: 157-164, 2008.
92. Ikebe M, Hartshorne DJ. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem 260: 10027-10031, 1985.
93. Ikebe M, Hartshorne DJ, Elzinga M. Identification, phosphorylation, and dephosphorylation of a second site for myosin light chain kinase on the 20, 000-dalton light chain of smooth muscle myosin. J Biol Chem 261: 36-39, 1986.
94. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353: 417-439, 2001.
95. Jeon SB, Jin F, Kim JI, Kim SH, Suk K, Chae SC, Jun JE, Park WH, Kim IK. A role for Rho kinase in vascular contraction evoked by sodium fluoride. Biochem Biophys Res Commun 343: 27-33, 2006.
96. Jeon SB, Kim G, Kim JI, Seok YM, Kim SH, Suk K, Shin HM, Lee YH, Kim IK. Flavone inhibits vascular contraction by decreasing phos-phorylation of the myosin phosphatase target subunit. Clin Exp Pharmacol Physiol 34: 1116-1120, 2007.
97. Johnson D, Cohen P, Chen MX, Chen YH, Cohen PT. Identification of the regions on the M110 subunit of protein phosphatase 1M that interact with the M21 subunit and with myosin. Eur J Biochem 244: 931-939, 1997.
98. Johnson DF, Moorhead G, Caudwell FB, Cohen P, Chen YH, Chen MX, Cohen PT. Identification of protein-phosphatase-1-binding do-mains on the glycogen and myofibrillar targetting subunits. Eur J Biochem 239: 317-325, 1996.
99. 2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response. J Physiol 587: 2537-2553, 2009.
100. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25: 593-620, 1985.
101. Kapiloff MS, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardi-omyocyte nuclear envelope. J Cell Sci 114: 3167-3176, 2001.
102. Karaki H, Mitsui M, Nagase H, Ozaki H, Shibata S, Uemura D. Inhibitory effect of a toxin okadaic acid, isolated from the black sponge, on smooth muscle and platelets. Br J Pharmacol 98: 590-596, 1989.
103. Karim SM, Rhee AY, Given AM, Faulx MD, Hoit BD, Brozovich FV. Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ Res 95: 612-618, 2004.
104. Khan RN, Hamoud H, Warren A, Wong LF, Arulkumaran S. Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy. Am J Obstet Gynecol 191: 315-321, 2004.
105. Khatri JJ, Joyce KM, Brozovich FV, Fisher SA. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001.
106. 2+ sensitization force of smooth muscle contrac-tion. J Biol Chem 284: 21569-21579, 2009.
107. Khromov AS, Momotani K, Jin L, Artamonov MV, Shannon J, Eto M, Somlyo AV. Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle. J Biol Chem 287: 20975-20985, 2012.
108. 2+ and de-creased cGMP-induced relaxation. Proc Natl Acad Sci USA 103: 2440-2445, 2006.
109. Kimura M, Suzuki Y, Satoh S, Takayasu M, Shibuya M, Sugita K. Vasodilatory effects of okadaic acid on the canine cerebral artery. Brain Res Bull 30: 701-704, 1993.
110. 2+ sensitization in rabbit smooth muscle. J Physiol 546: 879-889, 2003.
111. Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphoryla-tion of CPI-17 and MYPT1. J Physiol 587: 3587-3603, 2009.
112. 2+ sensitization in Triton X-100-demem-branated rabbit arterial smooth muscle. J Physiol 520: 139-152, 1999.
113. Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273: 13367-13370, 1998.
114. Koga Y, Ikebe M. p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA. J Biol Chem 280: 4983-4991, 2005.
115. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475: 197-200, 2000.
116. Ku CY, Word RA, Sanborn BM. Differential expression of protein kinase A, AKAP79, and PP2B in pregnant human myometrial mem-branes prior to and during labor. J Soc Gynecol Investig 12: 421-427, 2005.
117. Kume H, Takeda N, Oguma T, Ito S, Kondo M, Ito Y, Shimokata K. Sphingosine 1-phosphate causes airway hyper-reactivity by Rho-medi-ated myosin phosphatase inactivation. J Pharmacol Exp Ther 320: 766-773, 2007.
118. Lambert H, Charette SJ, Bernier AF, Guimond A, Landry J. HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J Biol Chem 274: 9378-9385, 1999.
119. Larsen JK, Yamboliev IA, Weber LA, Gerthoffer WT. Phosphoryla-tion of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle. Am J Physiol Lung Cell Mol Physiol 273: L930-L940, 1997.
120. Lartey J, Gampel A, Pawade J, Mellor H, Bernal AL. Expression of RND proteins in human myometrium. Biol Reprod 75: 452-461, 2006.
121. Lartey J, Martin J, Sweeney M, Robson S, Taggart MJ. MYPT3 and TIMAP-prenylatable myosin II targeting units and uterine quiescence in humans (Abstract). Reprod Sci 17: 2010.
122. Lartey J, Martin J, Sweeney M, Robson S, Taggart MJ. Up-regulation of MYPT1 LZ positive isovariants during gestation and cyclic nucleotide induced desensitisation in pregnant human myometrium (Abstract). Reprod Sci 17: 2010.
123. Lartey J, Smith M, Pawade J, Strachan B, Mellor H, Lopez Bernal A. Upregulation of myometrial Rho effector proteins (PKN1 and DI-APH1) and CPI-17 (PPP1R14A) phosphorylation in human pregnancy is associated with increased GTP-RhoA in spontaneous preterm labor. Biol Reprod 76: 971-982, 2007.
124. Lechward K, Awotunde OS, Swiatek W, Muszynska G. Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochim Pol 48: 921-933, 2001.
125. + channels by calcineurin in rabbit coronary arterial myocytes. J Physiol 552: 701-714, 2003.
126. 2+ desensitization in vascular smooth muscle by activating the myosin light chain phospha-tase. J Biol Chem 272: 5063-5068, 1997.
127. Lee YJ, Lee DH, Cho CK, Bae S, Jhon GJ, Lee SJ, Soh JW, Lee YS. HSP25 inhibits protein kinase Cδ-mediated cell death through direct interaction. J Biol Chem 280: 18108-18119, 2005.
128. Leroy MJ, Cedrin I, Breuiller M, Giovagrandi Y, Ferre F. Correla-tion between selective inhibition of the cyclic nucleotide phosphodies-terases and the contractile activity in human pregnant myometrium near term. Biochem Pharmacol 38: 9-15, 1989.
129. 2+]i. Am J Physiol Lung Cell Mol Physiol 289: L574-L582, 2005.
130. Liu CW, Wang RH, Dohadwala M, Schonthal AH, Villa-Moruzzi E, Berndt N. Inhibitory phosphorylation of PP1α catalytic subunit during the G1/S transition. J Biol Chem 274: 29470-29475, 1999.
131. Lontay B, Bodoor K, Weitzel DH, Loiselle D, Fortner C, Lengyel S, Zheng D, Devente J, Hickner R, Haystead TA. Smoothelin-like 1 protein regulates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy. J Biol Chem 285: 29357-29366, 2010.
132. Lu Y, Zhang H, Gokina N, Mandala M, Sato O, Ikebe M, Osol G, Fisher SA. Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy. Am J Physiol Cell Physiol 294: C564-C571, 2008.
133. MacDonald JA, Borman MA, Muranyi A, Somlyo AV, Hartshorne DJ, Haystead TA. Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci USA 98: 2419-2424, 2001.
134. MacDonald JA, Walker LA, Nakamoto RK, Gorenne I, Somlyo AV, Somlyo AP, Haystead TA. Phosphorylation of telokin by cyclic nucle-otide kinases and the identification of in vivo phosphorylation sites in smooth muscle. FEBS Lett 479: 83-88, 2000.
135. MacIntyre DA, Tyson EK, Read M, Smith R, Yeo G, Kwek K, Chan EC. Contraction in human myometrium is associated with changes in small heat shock proteins. Endocrinology 149: 245-252, 2008.
136. 2+ release by mTOR and calcineurin. J Cell Sci 118: 5443-5451, 2005.
137. 2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR. Br J Pharmacol 158: 1112-1120, 2009.
138. Maki J, Hirano M, Hoka S, Kanaide H, Hirano K. Involvement of reactive oxygen species in thrombin-induced pulmonary vasoconstric-tion. Am J Respir Crit Care Med 182: 1435-1444, 2010.
139. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, Kass RS. Requirement of a macromolecular signaling complex for β-adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295: 496-499, 2002.
140. Mausbacher N, Schreiber TB, Machatti M, Schaab C, Daub H. Proteome-wide analysis of temporal phosphorylation dynamics in lyso-phosphatidic acid-induced signaling. Proteomics 122: 3485-3498, 2012.
141. McPartlin AE, Barker HM, Cohen PT. Identification of a third alter-natively spliced cDNA encoding the catalytic subunit of protein phos-phatase 2Bβ. Biochim Biophys Acta 1088: 308-310, 1991.
142. Mehats C, Tanguy G, Paris B, Robert B, Pernin N, Ferre F, Leroy MJ. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors. J Pharmacol Exp Ther 292: 817-823, 2000.
143. Mehrabadi A, Hutcheon JA, Lee L, Liston RM, Joseph K. Trends in postpartum hemorrhage from 2000 to 2009: a population-based study. BMC Pregnancy Childbirth 12: 108, 2012.
144. Mizuno Y, Isotani E, Huang J, Ding H, Stull JT, Kamm KE. Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo. Am J Physiol Cell Physiol 295: C358-C364, 2008.
145. Moore F, Bernal AL. Myosin light chain kinase and the onset of labour in humans. Exp Physiol 86: 313-318, 2001.
146. Moore F, Da Silva C, Wilde JI, Smarason A, Watson SP, Lopez Bernal A. Upregulation of p21-and RhoA-activated protein kinases in human pregnant myometrium. Biochem Biophys Res Commun 269: 322-326, 2000.
147. Morales S, Diez A, Puyet A, Camello PJ, Camello-Almaraz C, Bautista JM, Pozo MJ. Calcium controls smooth muscle TRPC gene transcription via the CaMK/calcineurin-dependent pathways. Am J Physiol Cell Physiol 292: C553-C563, 2007.
148. Morgado M, Cairrao E, Santos-Silva AJ, Verde I. Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci 69: 247-266, 2012.
149. 2+ sensitization in intestinal smooth muscle. Neurogastro-enterol Motil 23: 1111-1122, 2011.
150. Mulder J, Ariaens A, van den Boomen D, Moolenaar WH. p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis. Mol Biol Cell 15: 5516-5527, 2004.
151. Mulder J, Poland M, Gebbink MF, Calafat J, Moolenaar WH, Kranenburg O. p116Rip is a novel filamentous actin-binding protein. J Biol Chem 278: 27216-27223, 2003.
152. Muramatsu T, Kincaid RL. Molecular cloning and chromosomal map-ping of the human gene for the testis-specific catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin A). Biochem Biophys Res Commun 188: 265-271, 1992.
153. Muranyi A, Derkach D, Erdodi F, Kiss A, Ito M, Hartshorne DJ. Phosphorylation of Thr695and Thr850on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett 579: 6611-6615, 2005.
154. Muranyi A, MacDonald JA, Deng JT, Wilson DP, Haystead TA, Walsh MP, Erdodi F, Kiss E, Wu Y, Hartshorne DJ. Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J 366: 211-216, 2002.
155. Murata K, Hirano K, Villa-Moruzzi E, Hartshorne DJ, Brautigan DL. Differential localization of myosin and myosin phosphatase subunits in smooth muscle cells and migrating fibroblasts. Mol Biol Cell 8: 663-673, 1997.
156. Murthy KS. Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5: an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1. Br J Pharmacol 153: 1214-1224, 2008.
157. Murthy KS, Sriwai W. Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A. Am J Physiol Gastrointest Liver Physiol 294: G327-G335, 2008.
158. Myatt L, Eschenbach DA, Lye SJ, Mesiano S, Murtha AP, Williams SM, Pennell CE. A standardized template for clinical studies in preterm birth. Reprod Sci 19: 474-482, 2012.
159. Nakamura K, Koga Y, Sakai H, Homma K, Ikebe M. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res 101: 712-722, 2007.
160. Nakamura M, Ichikawa K, Ito M, Yamamori B, Okinaka T, Isaka N, Yoshida Y, Fujita S, Nakano T. Effects of the phosphorylation of myosin phosphatase by cyclic GMP-dependent protein kinase. Cell Signal 11: 671-676, 1999.
161. 2+ sparklet activity in arterial smooth muscle. J Gen Physiol 127: 611-622, 2006.
162. 2+ channels. Proc Natl Acad Sci USA 102: 11112-11117, 2005.
163. 2+ sparklets and angiotensin II-induced hyperten-sion. Circ Res 102: e1-e11, 2008.
164. Neppl RL, Lubomirov LT, Momotani K, Pfitzer G, Eto M, Somlyo AV. Thromboxane A2-induced bi-directional regulation of cerebral arte-rial tone. J Biol Chem 284: 6348-6360, 2009.
165. +channels in arterial smooth muscle and contributes to hypertension. J Biol Chem 282: 3231-3240, 2007.
166. Niiro N, Koga Y, Ikebe M. Agonist-induced changes in the phosphor-ylation of the myosin-binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem J 369: 117-128, 2003.
167. Niiro N, Nishimura J, Sakihara C, Nakano H, Kanaide H. Up-regulation of Rho A and Rho-kinase mRNAs in the rat myometrium during pregnancy. Biochem Biophys Res Commun 230: 356-359, 1997.
168. Norman JE, Ward LM, Martin W, Cameron AD, McGrath JC, Greer IA, Cameron IT. Effects of cGMP and the nitric oxide donors glyceryl trinitrate and sodium nitroprusside on contractions in vitro of isolated myometrial tissue from pregnant women. J Reprod Fertil 110: 249-254, 1997.
169. Obara K, Ito Y, Shimada H, Nakayama K. The relaxant effect of okadaic acid on canine basilar artery involves activation of PKCα and phosphorylation of the myosin light chain at Thr-9. Eur J Pharmacol 598: 87-93, 2008.
170. Obara K, Mitate A, Nozawa K, Watanabe M, Ito Y, Nakayama K. Interactive role of protein phosphatase 2A and protein kinase Cα in the stretch-induced triphosphorylation of myosin light chain in canine cere-bral artery. J Vasc Res 47: 115-127, 2010.
171. Obara K, Uchino M, Koide M, Yamanaka A, Nakayama K. Stretch-induced triphosphorylation of myosin light chain and myogenic tone in canine basilar artery. Eur J Pharmacol 534: 141-151, 2006.
172. Oger S, Mehats C, Barnette MS, Ferre F, Cabrol D, Leroy MJ. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Biol Reprod 70: 458-464, 2004.
173. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648, 2006.
174. 2+/calcineurin regulation of cloned vascular K ATP channels: crosstalk with the protein kinase A pathway. Br J Pharmacol 157: 554-564, 2009.
175. Ozaki H, Yasuda K, Kim YS, Egawa M, Kanzaki H, Nakazawa H, Hori M, Seto M, Karaki H. Possible role of the protein kinase C/CPI-17 pathway in the augmented contraction of human myometrium after gestation. Br J Pharmacol 140: 1303-1312, 2003.
176. Pang H, Guo Z, Su W, Xie Z, Eto M, Gong MC. RhoA-Rho kinase pathway mediates thrombin-and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am J Physiol Cell Physiol 289: C352-C360, 2005.
177. Panner BJ, Honig CR. Filament ultrastructure and organization in vertebrate smooth muscle. Contraction hypothesis based on localization of actin and myosin. J Cell Biol 35: 303-321, 1967.
178. Patel CA, Rattan S. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK. Am J Physiol Gastrointest Liver Physiol 292: G1747-G1756, 2007.
179. Patel CA, Rattan S. Spontaneously tonic smooth muscle has character-istically higher levels of RhoA/ROK compared with the phasic smooth muscle. Am J Physiol Gastrointest Liver Physiol 291: G830-G837, 2006.
180. Patil SB, Bitar KN. RhoA-and PKC-α-mediated phosphorylation of MYPT and its association with HSP27 in colonic smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 290: G83-G95, 2006.
181. Patil SB, Pawar MD, Bitar KN. Phosphorylated HSP27 essential for acetylcholine-induced association of RhoA with PKCα. Am J Physiol Gastrointest Liver Physiol 286: G635-G644, 2004.
182. Patil SB, Tsunoda Y, Pawar MD, Bitar KN. Translocation and association of ROCK-II with RhoA and HSP27 during contraction of rabbit colon smooth muscle cells. Biochem Biophys Res Commun 319: 95-102, 2004.
183. Pato MD, Sutherland C, Winder SJ, Walsh MP. Smooth-muscle caldesmon phosphatase is SMP-I, a type 2A protein phosphatase. Biochem J 293: 35-41, 1993.
184. Paul J, Maiti K, Read M, Hure A, Smith J, Chan EC, Smith R. Phasic phosphorylation of caldesmon and ERK 1/2 during contractions in human myometrium. PLos One 6: e21542, 2011.
185. Payne MC, Zhang HY, Prosdocimo T, Joyce KM, Koga Y, Ikebe M, Fisher SA. Myosin phosphatase isoform switching in vascular smooth muscle development. J Mol Cell Cardiol 40: 274-282, 2006.
186. B-crystallin. J Cell Sci 112: 2099-2112, 1999.
187. Pinheiro AS, Marsh JA, Forman-Kay JD, Peti W. Structural signature of the MYPT1-PP1 interaction. J Am Chem Soc 133: 73-80, 2011.
188. Pont JN, McArdle CA, Lopez Bernal A. Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells. Mol Endocrinol 26: 1743-1756, 2012.
189. 2+ -desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP. Am J Physiol Cell Physiol 290: C1552-C1559, 2006.
190. Puetz S, Lubomirov LT, Pfitzer G. Regulation of smooth muscle contraction by small GTPases. Physiology (Bethesda) 24: 342-356, 2009.
191. Puetz S, Schroeter MM, Piechura H, Reimann L, Hunger MS, Lubomirov LT, Metzler D, Warscheid B, Pfitzer G. New insights into myosin phosphorylation during cyclic nucleotide-mediated smooth muscle relaxation. J Muscle Res Cell Motil 33: 471-483, 2012.
192. Purves GI, Kamishima T, Davies LM, Quayle JM, Dart C. Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels. J Physiol 587: 3639-3650, 2009.
193. Qi F, Ogawa K, Tokinaga Y, Uematsu N, Minonishi T, Hatano Y. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation. Anesth Analg 109: 412-417, 2009.
194. Rattan S, Singh J. RhoA/ROCK pathway is the major molecular determinant of basal tone in intact human internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 302: G664-G675, 2012.
195. Redden JM, Dodge-Kafka KL. AKAP phosphatase complexes in the heart. J Cardiovasc Pharmacol 58: 354-362, 2011.
196. Rembold CM, Foster DB, Strauss JD, Wingard CJ, Eyk JE. cGMP-mediated phosphorylation of heat shock protein 20 may cause smooth muscle relaxation without myosin light chain dephosphorylation in swine carotid artery. J Physiol 524: 865-878, 2000.
197. Rice RV, Moses JA, McManus GM, Brady AC, Blasik LM. The organization of contractile filaments in a mammalian smooth muscle. J Cell Biol 47: 183-196, 1970.
198. Riddick N, Ohtani K, Surks HK. Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase. J Cell Biochem 103: 1158-1170, 2008.
199. Rigbolt KT, Prokhorova TA, Akimov V, Henningsen J, Johansen PT, Kratchmarova I, Kassem M, Mann M, Olsen JV, Blagoev B. System-wide temporal characterization of the proteome and phosphopro-teome of human embryonic stem cell differentiation. Sci Signal 4: rs3, 2011.
200. Riley M, Baker PN, Tribe RM, Taggart MJ. Expression of scaffold-ing, signalling and contractile-filament proteins in human myometria: effects of pregnancy and labour. J Cell Mol Med 9: 122-134, 2005.
201. Riley M, Wu X, Baker PN, Taggart MJ. Gestational-dependent changes in the expression of signal transduction and contractile filament-associated proteins in mouse myometrium. J Soc Gynecol Investig 12: e33-e43, 2005.
202. Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev 80: 1483-1521, 2000.
203. 2+ -dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vas-cular smooth muscle contraction. Circ Res 93: 548-556, 2003.
204. Sasaki K, Shima H, Kitagawa Y, Irino S, Sugimura T, Nagao M. Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1α gene in rat hepatocellular carcinomas. Jpn J Cancer Res 81: 1272-1280, 1990.
205. 2+ channels by activation of protein phosphatase type 2B and by direct interaction with the channel. J Gen Physiol 110: 503-513, 1997.
206. Schulz RA, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 266: 1-16, 2004.
207. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
208. 2+ -dependent activation of phospho-inositide 3-kinase class II α-isoform-Rho axis in blood vessels of spon-taneously hypertensive rats. Hypertension 56: 934-941, 2010.
209. 2+ -dependent and-independent mechanisms. J Physiol 560: 839-855, 2004.
210. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell 139: 468-484, 2009.
211. Shibata S, Satake N, Morikawa M, Kown SC, Karaki H, Kurahashi K, Sawada T, Kodama I. The inhibitory action of okadaic acid on mechanical responses in guinea-pig vas deferens. Eur J Pharmacol 193: 1-7, 1991.
212. Shin HM, Je HD, Gallant C, Tao TC, Hartshorne DJ, Ito M, Morgan KG. Differential association and localization of myosin phosphatase subunits during agonist-induced signal transduction in smooth muscle. Circ Res 90: 546-553, 2002.
213. Shirinsky VP, Vorotnikov AV, Birukov KG, Nanaev AK, Collinge M, Lukas TJ, Sellers JR, Watterson DM. A kinase-related protein stabilizes unphosphorylated smooth muscle myosin minifilaments in the presence of ATP. J Biol Chem 268: 16578-16583, 1993.
214. Shynlova O, Tsui P, Jaffer S, Lye SJ. Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour. Eur J Obstet Gynecol Reprod Biol 144 Suppl 1: S2-S10, 2009.
215. Silver DL, Vorotnikov AV, Watterson DM, Shirinsky VP, Sellers JR. Sites of interaction between kinase-related protein and smooth muscle myosin. J Biol Chem 272: 25353-25359, 1997.
216. Singh A, Redden JM, Kapiloff MS, Dodge-Kafka KL. The large isoforms of A-kinase anchoring protein 18 mediate the phosphorylation of inhibitor-1 by protein kinase A and the inhibition of protein phospha-tase 1 activity. Mol Pharmacol 79: 533-540, 2011.
217. Skinner JA, Saltiel AR. Cloning and identification of MYPT3: a prenylatable myosin targetting subunit of protein phosphatase 1. Biochem J 356: 257-267, 2001.
218. Slater DM, Astle S, Woodcock N, Chivers JE, de Wit NC, Thornton S, Vatish M, Newton R. Anti-inflammatory and relaxatory effects of prostaglandin E2 in myometrial smooth muscle. Mol Hum Reprod 12: 89-97, 2006.
219. Smith AF, Bigsby RM, Word RA, Herring BP. A 310-bp minimal promoter mediates smooth muscle cell-specific expression of telokin. Am J Physiol Cell Physiol 274: C1188-C1195, 1998.
220. Sobieszek A, Andruchov OY, Nieznanski K. Kinase-related protein (telokin) is phosphorylated by smooth-muscle myosin light-chain kinase and modulates the kinase activity. Biochem J 328: 425-430, 1997.
221. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
222. Somlyo AP, Somlyo AV. Ultrastructural aspects of activation and contraction of vascular smooth muscle. Fed Proc 35: 1288-1293, 1976.
223. Sriwai W, Zhou H, Murthy KS. Gq-dependent signalling by the lysophosphatidic acid receptor LPA3in gastric smooth muscle: reciprocal regulation of MYPT1 phosphorylation by Rho kinase and cAMP-inde-pendent PKA. Biochem J 411: 543-551, 2008.
224. Stemmer PM, Klee CB. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry 33: 6859-6866, 1994.
225. 2+ -and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett 137: 80-84, 1982.
226. Surks HK, Mendelsohn ME. Dimerization of cGMP-dependent protein kinase 1? and the myosin-binding subunit of myosin phosphatase: role of leucine zipper domains. Cell Signal 15: 937-944, 2003.
227. Surks HK, Richards CT, Mendelsohn ME. Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA. J Biol Chem 278: 51484-51493, 2003.
228. Sutherland C, Walsh MP. Myosin regulatory light chain diphosphory-lation slows relaxation of arterial smooth muscle. J Biol Chem 287: 24064-24076, 2012.
229. Swaney DL, Wenger CD, Thomson JA, Coon JJ. Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 106: 995-1000, 2009.
230. Taggart MJ, Arthur P, Zielnik B, Mitchell BF. Molecular pathways regulating contractility in rat uterus through late gestation and parturition. Am J Obstet Gynecol 207: 76 e15-e24, 2012.
231. Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y. RhoA/Rho-kinase cascade is involved in oxyto-cin-induced rat uterine contraction. Endocrinology 143: 920-929, 2002.
232. Takahashi N, Ito M, Tanaka J, Nakano T, Kaibuchi K, Odai H, Takemura K. Localization of the gene coding for myosin phosphatase, target subunit 1 (MYPT1) to human chromosome 12q15-q21. Genomics 44: 150-152, 1997.
233. Takizawa N, Niiro N, Ikebe M. Dephosphorylation of the two regula-tory components of myosin phosphatase, MBS and CPI17. FEBS Lett 515: 127-132, 2002.
234. Tan I, Ng CH, Lim L, Leung T. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J Biol Chem 276: 21209-21216, 2001.
235. Tansey MG, Hori M, Karaki H, Kamm KE, Stull JT. Okadaic acid uncouples myosin light chain phosphorylation and tension in smooth muscle. FEBS Lett 270: 219-221, 1990.
236. 2+ /calmodulin-dependent protein kinases II in human atrial myocytes. Circ Res 85: 810-819, 1999.
237. Tian L, Coghill LS, McClafferty H, MacDonald SH, Antoni FA, Ruth P, Knaus HG, Shipston MJ. Distinct stoichiometry of BKCa channel tetramer phosphorylation specifies channel activation and inhi-bition by cAMP-dependent protein kinase. Proc Natl Acad Sci USA 101: 11897-11902, 2004.
238. Tichenor JN. Stretch-Activated Potassium Channels in Human Myome-trium and Aspects of cGMP Signaling (Dissertation). Reno, NV: Univer-sity of Nevada, 2008, p. 204.
239. Toth A, Kiss E, Herberg FW, Gergely P, Hartshorne DJ, Erdodi F. Study of the subunit interactions in myosin phosphatase by surface plasmon resonance. Eur J Biochem 267: 1687-1697, 2000.
240. Totsukawa G, Yamakita Y, Yamashiro S, Hosoya H, Hartshorne DJ, Matsumura F. Activation of myosin phosphatase targeting subunit by mitosis-specific phosphorylation. J Cell Biol 144: 735-744, 1999.
241. Tsai MH, Jiang MJ. Rho-kinase-mediated regulation of receptor-ago-nist-stimulated smooth muscle contraction. Pflügers Arch 453: 223-232, 2006.
242. Tung HY, Alemany S, Cohen P. The protein phosphatases involved in cellular regulation. 2. Purification, subunit structure and properties of protein phosphatases-2A0, 2A1, and 2A2 from rabbit skeletal muscle. Eur J Biochem 148: 253-263, 1985.
243. Tyson EK, Macintyre DA, Smith R, Chan EC, Read M. Evidence that a protein kinase A substrate, small heat-shock protein 20, modulates myometrial relaxation in human pregnancy. Endocrinology 149: 6157-6165, 2008.
244. Ueki K, Muramatsu T, Kincaid RL. Structure and expression of two isoforms of the murine calmodulin-dependent protein phosphatase reg-ulatory subunit (calcineurin B). Biochem Biophys Res Commun 187: 537-543, 1992.
245. 2+ sensitization of arterial mus-cle. Am J Physiol Cell Physiol 285: C1377-C1385, 2003.
246. Vallenius T, Vaahtomeri K, Kovac B, Osiceanu AM, Viljanen M, Makela TP. An association between NUAK2 and MRIP reveals a novel mechanism for regulation of actin stress fibers. J Cell Sci 124: 384-393, 2011.
247. Velasco G, Armstrong C, Morrice N, Frame S, Cohen P. Phosphor-ylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850induces its dissociation from myosin. FEBS Lett 527: 101-104, 2002.
248. Verli J, Klukovits A, Kormanyos Z, Hajagos-Toth J, Ducza E, Seres AB, Falkay G, Gaspar R. Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro. J Obstet Gynaecol Res 39: 31-39, 2013.
249. Vetterkind S, Lee E, Sundberg E, Poythress RH, Tao TC, Preuss U, Morgan KG. Par-4: a new activator of myosin phosphatase. Mol Biol Cell 21: 1214-1224, 2010.
250. Vetterkind S, Morgan KG. The pro-apoptotic protein Par-4 facilitates vascular contractility by cytoskeletal targeting of ZIPK. J Cell Mol Med 13: 887-895, 2009.
251. Virshup DM, Shenolikar S. From promiscuity to precision: protein phosphatases get a makeover. Mol Cell 33: 537-545, 2009.
252. Walsh MP. Vascular smooth muscle myosin light chain diphosphoryla-tion: mechanism, function, and pathological implications. IUBMB Life 63: 987-1000, 2011.
253. Wang T, Kendig DM, Smolock EM, Moreland RS. Carbachol-induced rabbit bladder smooth muscle contraction: roles of protein kinase C and Rho kinase. Am J Physiol Renal Physiol 297: F1534-F1542, 2009.
254. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y, Sugimoto N, Inoki I, Kimura T, Kuwaki T, Takuwa Y. Class II phos-phoinositide 3-kinase α-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 394: 581-592, 2006.
255. Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X, Surks HK. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res 104: 531-540, 2009.
256. 2+ -desensitizing hypoxic vasorelaxation: pivotal role for the myosin binding subunit of myosin phosphatase (MYPT1) in porcine coronary artery. J Physiol 572: 259-267, 2006.
257. Watanabe M, Takano-Ohmuro H. Extensive skinning of cell membrane diminishes the force-inhibiting effect of okadaic acid on smooth muscles of guinea pig hepatic portal vein. Jpn J Physiol 52: 141-147, 2002.
258. White BG, MacPhee DJ. Distension of the uterus induces HspB1 expression in rat uterine smooth muscle. Am J Physiol Regul Integr Comp Physiol 301: R1418-R1426, 2011.
259. +channels: role of protein phosphatase-2B. Circ Res 87: 1019-1025, 2000.
260. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr855, but not Thr697. Biochem J 389: 763-774, 2005.
261. Winder SJ, Pato MD, Walsh MP. Purification and characterization of calponin phosphatase from smooth muscle. Effect of dephosphorylation on calponin function. Biochem J 286: 197-203, 1992.
262. Woodrum DA, Brophy CM, Wingard CJ, Beall A, Rasmussen H. Phosphorylation events associated with cyclic nucleotide-dependent in-hibition of smooth muscle contraction. Am J Physiol Heart Circ Physiol 277: H931-H939, 1999.
263. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535: 553-564, 2001.
264. Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T. Agonist-and depolarization-induced signals for myosin light chain phosphoryla-tion and force generation of cultured vascular smooth muscle cells. J Cell Sci 119: 1769-1780, 2006.
265. Wooldridge AA, Fortner CN, Lontay B, Akimoto T, Neppl RL, Face-mire C, Datto MB, Kwon A, McCook E, Li P, Wang S, Thresher RJ, Miller SE, Perriard JC, Gavin TP, Hickner RC, Coffman TM, Somlyo AV, Yan Z, Haystead TA. Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle. J Biol Chem 283: 11850-11859, 2008.
266. Wooldridge AA, MacDonald JA, Erdodi F, Ma C, Borman MA, Hartshorne DJ, Haystead TA. Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of serine 695 in response to cyclic nucleotides. J Biol Chem 279: 34496-34504, 2004.
267. Wu X, Haystead TA, Nakamoto RK, Somlyo AV, Somlyo AP. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase. J Biol Chem 273: 11362-11369, 1998.
268. Wu X, Somlyo AV, Somlyo AP. Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. Biochem Biophys Res Commun 220: 658-663, 1996.
269. Yamamoto H, Takashima S, Shintani Y, Yamazaki S, Seguchi O, Nakano A, Higo S, Kato H, Liao Y, Asano Y, Minamino T, Mat-sumura Y, Takeda H, Kitakaze M. Identification of a novel substrate for TNFα-induced kinase NUAK2. Biochem Biophys Res Commun 365: 541-547, 2008.
270. Yamashiro S, Yamakita Y, Totsukawa G, Goto H, Kaibuchi K, Ito M, Hartshorne DJ, Matsumura F. Myosin phosphatase-targeting sub-unit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev Cell 14: 787-797, 2008.
271. Yamawaki K, Ito M, Machida H, Moriki N, Okamoto R, Isaka N, Shimpo H, Kohda A, Okumura K, Hartshorne DJ, Nakano T. Identification of human CPI-17, an inhibitory phosphoprotein for myosin phosphatase. Biochem Biophys Res Commun 285: 1040-1045, 2001.
272. 2+ -binding sites of calcineurin B mediate conformational changes in calcineurin A. Biochemistry 39: 16147-16154, 2000.
273. 2+ -induced, Rho-and Rho kinase-dependent regulation of myosin phosphatase and contraction in iso-lated vascular smooth muscle cells. Mol Pharmacol 71: 912-920, 2007.
274. Yuen S, Ogut O, Brozovich FV. MYPT1 protein isoforms are differ-entially phosphorylated by protein kinase G. J Biol Chem 286: 37274-37279, 2011.
275. Zagorska A, Deak M, Campbell DG, Banerjee S, Hirano M, Aizawa S, Prescott AR, Alessi DR. New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal 3: ra25, 2010.
276. Zhang H, Fisher SA. Conditioning effect of blood flow on resistance artery smooth muscle myosin phosphatase. Circ Res 100: 730-737, 2007.
277. Zhong M, Murtazina DA, Phillips J, Ku CY, Sanborn BM. Multiple signals regulate phospholipase Cβ3 in human myometrial cells. Biol Reprod 78: 1007-1017, 2008.
278. Zhou XB, Arntz C, Kamm S, Motejlek K, Sausbier U, Wang GX, Ruth P, Korth M. A molecular switch for specific stimulation of the BKCa channel by cGMP and cAMP kinase. J Biol Chem 276: 43239-43245, 2001.
279. + currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells. J Biol Chem 271: 19760-19767, 1996.
280. Zhou XB, Schlossmann J, Hofmann F, Ruth P, Korth M. Regulation of stably expressed and native BK channels from human myometrium by cGMP-and cAMP-dependent protein kinase. Pflügers Arch 436: 725-734, 1998.
281. Zhou XB, Wang GX, Ruth P, Huneke B, Korth M. BKCa channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 279: C1751-C1759, 2000.
282. Zhou XB, Wulfsen I, Utku E, Sausbier U, Sausbier M, Wieland T, Ruth P, Korth M. Dual role of protein kinase C on BK channel regulation. Proc Natl Acad Sci USA 107: 8005-8010, 2010.
283. Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol 60: 1225-1235, 2000.